Do you offer adjuvant therapy for localized medullary carcinoma of the ascending colon that is MSI-H?  

Do you use the same high risk factors as adenocarcinoma when deciding on adjuvant treatment for early stage disease?



Answer from: Medical Oncologist at Community Practice